The Clinical Significance of PR, ER, NF-κB, and TNF-αin Breast Cancer

Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer

(2013) Marzieh Panahi et al.   Asian Pacific Journal of Cancer Prevention

Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth

(2013) Mingxia Yu et al.   CANCER RESEARCH

Selective suppression of endothelial cytokine production by progesterone receptor

(2013) Lauren M. Goddard et al.   VASCULAR PHARMACOLOGY

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

(2012) Isabelle Soerjomataram et al.   LANCET

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

(2011) Hasan Korkaya et al.   JOURNAL OF CLINICAL INVESTIGATION

Similar NF-κB Gene Signatures in TNF-α Treated Human Endothelial Cells and Breast Tumor Biopsies

(2011) Martine Perrot-Applanat et al.   PLoS One

Combinatorial biomarker expression in breast cancer

(2010) Emad A. Rakha et al.   BREAST CANCER RESEARCH AND TREATMENT

Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics

(2010) Jodi E. Goldberg et al.   CURRENT DRUG TARGETS

Production of Proinflammatory Cytokines and Chemokines During Neuroinflammation: Novel Roles for Estrogen Receptors α and β

(2010) Candice M. Brown et al.   ENDOCRINOLOGY

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

(2009) Shuzhen Liu et al.   BREAST CANCER RESEARCH AND TREATMENT